92 related articles for article (PubMed ID: 6945144)
1. The prognosis in osteosarcoma: Norwegian National Data.
Harvei S; Solheim O
Cancer; 1981 Oct; 48(8):1719-23. PubMed ID: 6945144
[TBL] [Abstract][Full Text] [Related]
2. Time-trends on incidence and survival in a nationwide and unselected cohort of patients with skeletal osteosarcoma.
Berner K; Johannesen TB; Berner A; Haugland HK; Bjerkehagen B; Bøhler PJ; Bruland ØS
Acta Oncol; 2015 Jan; 54(1):25-33. PubMed ID: 24957555
[TBL] [Abstract][Full Text] [Related]
3. [The effect of resistance-related proteins on the prognosis and survival of patients with osteosarcoma: an immunohistochemical analysis].
Ozger H; Eralp L; Atalar AC; Toker B; Esberk Ateş L; Sungur M; Bilgiç B; Ayan I
Acta Orthop Traumatol Turc; 2009; 43(1):28-34. PubMed ID: 19293613
[TBL] [Abstract][Full Text] [Related]
4. Incidence, epidemiology and treatment results of osteosarcoma in Finland - a nationwide population-based study.
Sampo M; Koivikko M; Taskinen M; Kallio P; Kivioja A; Tarkkanen M; Böhling T
Acta Oncol; 2011 Nov; 50(8):1206-14. PubMed ID: 22023116
[TBL] [Abstract][Full Text] [Related]
5. The outcomes and prognostic factors in patients with osteosarcoma according to age: a Japanese nationwide study with focusing on the age differences.
Tsuda Y; Ogura K; Shinoda Y; Kobayashi H; Tanaka S; Kawai A
BMC Cancer; 2018 May; 18(1):614. PubMed ID: 29855362
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy in osteosarcoma. The Scandinavian Sarcoma Group experience.
Saeter G; Wiebe T; Wiklund T; Monge O; Wahlqvist Y; Engström K; Forestier E; Holmström T; Stenwig AE; Willén H; Brosjö O; Follerås G; Alvegård TA; Strander H
Acta Orthop Scand Suppl; 1999 Jun; 285():74-82. PubMed ID: 10429627
[No Abstract] [Full Text] [Related]
7. Post operative infection and increased survival in osteosarcoma patients: are they associated?
Jeys LM; Grimer RJ; Carter SR; Tillman RM; Abudu A
Ann Surg Oncol; 2007 Oct; 14(10):2887-95. PubMed ID: 17653803
[TBL] [Abstract][Full Text] [Related]
8. Improved survival associated with postoperative wound infection in dogs treated with limb-salvage surgery for osteosarcoma.
Lascelles BD; Dernell WS; Correa MT; Lafferty M; Devitt CM; Kuntz CA; Straw RC; Withrow SJ
Ann Surg Oncol; 2005 Dec; 12(12):1073-83. PubMed ID: 16252138
[TBL] [Abstract][Full Text] [Related]
9. Descriptive epidemiology and outcomes of bone sarcomas in adolescent and young adult patients in Japan.
Fukushima T; Ogura K; Akiyama T; Takeshita K; Kawai A
BMC Musculoskelet Disord; 2018 Aug; 19(1):297. PubMed ID: 30121085
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapy for the primary treatment of osteosarcoma: population effectiveness over 20 years.
Gill M; McCarthy M; Murrells T; Silcocks P
Lancet; 1988 Mar; 1(8587):689-92. PubMed ID: 2895220
[TBL] [Abstract][Full Text] [Related]
11. [Incidence of osteosarcomas and the average life span of rats receiving 90Sr].
Shvedov VL; Zaĭtsev IuA
Radiobiologiia; 1984; 24(4):489-94. PubMed ID: 6591284
[TBL] [Abstract][Full Text] [Related]
12. Osteosarcoma in Finland from 1971 through 1990: a nationwide study of epidemiology and outcome.
Sampo MM; Tarkkanen M; Kivioja AH; Taskinen MH; Sankila R; Böhling TO
Acta Orthop; 2008 Dec; 79(6):861-6. PubMed ID: 19085506
[TBL] [Abstract][Full Text] [Related]
13. Outcome of postradiation osteosarcoma does not correlate with chemotherapy response.
Lewis VO; Raymond K; Mirza AN; Lin P; Yasko AW
Clin Orthop Relat Res; 2006 Sep; 450():60-6. PubMed ID: 16906104
[TBL] [Abstract][Full Text] [Related]
14. Bone metastases in osteosarcoma patients treated with neoadjuvant or adjuvant chemotherapy: the Rizzoli experience in 52 patients.
Bacci G; Longhi A; Bertoni F; Briccoli A; Versari M; Pignotti E; Picci P
Acta Orthop; 2006 Dec; 77(6):938-43. PubMed ID: 17260205
[TBL] [Abstract][Full Text] [Related]
15. Age and dose of chemotherapy as major prognostic factors in a trial of adjuvant therapy of osteosarcoma combining two alternating drug combinations and early prophylactic lung irradiation. French Bone Tumor Study Group.
Cancer; 1988 Apr; 61(7):1304-11. PubMed ID: 3125957
[TBL] [Abstract][Full Text] [Related]
16. The extremity localized classic osteosarcomas have better survival than the axial non-classics.
Lin L; Deng S; Zhang F; Liang Y; Huang Z
World J Surg Oncol; 2018 Feb; 16(1):39. PubMed ID: 29471883
[TBL] [Abstract][Full Text] [Related]
17. P-glycoprotein expression in osteosarcoma: a basis for risk-adapted adjuvant chemotherapy.
Baldini N; Scotlandi K; Serra M; Picci P; Bacci G; Sottili S; Campanacci M
J Orthop Res; 1999 Sep; 17(5):629-32. PubMed ID: 10569469
[TBL] [Abstract][Full Text] [Related]
18. Osteosarcoma in young children.
Kozakewich H; Perez-Atayde AR; Goorin AM; Wilkinson RH; Gebhardt MC; Vawter GF
Cancer; 1991 Feb; 67(3):638-42. PubMed ID: 1985758
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of tumor suppressors in osteosarcoma before and after neoadjuvant chemotherapy.
Robl B; Pauli C; Botter SM; Bode-Lesniewska B; Fuchs B
BMC Cancer; 2015 May; 15():379. PubMed ID: 25956431
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Impact of Proximal
Berner K; Bruland ØS
Anticancer Res; 2019 May; 39(5):2459-2466. PubMed ID: 31092440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
